Updated:
Tennessee Oncology
Tennessee Oncology is one of the nation's largest community-based cancer care practices, operating for 50 years across a statewide footprint.
Tennessee Oncology
Tennessee Oncology marks its 50th year in 2026 as a community-based cancer care specialist headquartered in Nashville. It delivers a full spectrum of oncology services — medical oncology, radiation oncology, and access to clinical trials — across a network of clinics concentrated in Tennessee. Its model is clinical delivery, not investment. The group's scale, as one of the largest cancer care specialists in the United States, derives from patient volume and geographic coverage rather than from deploying a proprietary investment portfolio. The practice participates in clinical research and is nationally accredited, positioning it as both a care provider and a site for pharmaceutical-sponsored trials. Operational metrics such as total providers, exact clinic count, and annual patient volumes are not publicly consolidated. The organization is recognized as an employer, earning a designation as one of America's Greatest Workplaces, which underscores a workforce managed at significant scale. Tennessee Oncology structurally differs from a private equity-backed physician practice management company: it remains a physician-led, community-rooted operator. Its longevity and accreditation suggest an independent or partnership-based governance model, though its exact corporate structure and ownership have not been publicly detailed.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Nashville
Corporate office
Nashville, TN, United States
Sector focus
Frequently asked questions
How does Tennessee Oncology's model differ from a private equity-backed oncology platform?
Tennessee Oncology presents as a physician-led community practice — not a platform company organized by an institutional investor. While private equity has consolidated many oncology groups into for-profit management services organizations (MSOs), Tennessee Oncology's 50-year history, nonprofit-style accreditation, and community-rooted marketing language suggest it has resisted that model, though no specific governance documents are publicly available.
Does Tennessee Oncology provide access to clinical trials?
Yes. Its own materials cite 'the latest clinical trials' as part of its service offering. As a large-volume practice with national accreditation, it likely serves as a site for pharmaceutical and CRO-sponsored oncology trials, which differentiates it from smaller independent clinics.
Who runs the clinical operation day-to-day?
Tennessee Oncology does not list an executive leadership or physician partnership roster on its public-facing website. A detailed organizational chart — including named C-suite, managing physician partners, or a board of directors — is not disclosed.
Is Tennessee Oncology an investment vehicle of any kind?
No. The entity is an operating medical practice. It does not appear to manage third-party capital or function as a family office, venture capital fund, or institutional asset manager. Altss tracks it for allocator mapping, not because it is a deployer of capital.
What is the organization's known geographic footprint?
The practice is headquartered in Nashville and describes itself as a statewide network. Public materials reference multiple clinic locations within Tennessee; no satellite offices in other states or regions are confirmed on the current website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: